Bruno Besse Email and Phone Number
Chief Medical Officer
at
Quantum Genomics
Bruno Besse's email is b.besse@crossject.com
.
Bruno Besse Contact Details
Email
b.besse@crossject.com
Email
bruno.besse@bms.com
Email
bruno.besse@quantum-genomics.com
Bruno Besse Company Details
Company
Location
Paris, île De France, France
Website
Industry
Pharmaceuticals
Bruno Besse's Current Company
Quantum Genomics
Industry | Pharmaceuticals | |
Location | Paris, île De France, France |
Industry | Pharmaceuticals | |
Location | Paris, île De France, France |
Bruno Besse's Experience and Education
Hôpital Boucicaut Paris
Chef De Clinique Des Hôpitaux Assistant Des Universités
1993-11 to 1996-04
Associate European Medical Lead Apixaban
2011-05-01 to 2014-08
New Jersey, United States
Praticien Attaché Cardiologie
2000-09 to Unknown
Paris, île De France, France
Associate Medical Director Worldwide Cardiovascular
2014-08 to 2017-02
New Jersey, United States
Frequently Asked Questions about Bruno Besse
What company does Bruno Besse work for?
Bruno Besse works for Quantum Genomics
What is Bruno Besse's role in his workplace?
Bruno Besse's role in his workplace is
Chief Medical Officer .
Which industry does Bruno Besse work in currently?
Bruno Besse works in the industry
Pharmaceuticals.
What is Bruno Besse's email address?
Bruno Besse's email address is b.besse@crossject.com
What schools did Bruno Besse attended?
Bruno Besse attended
Paris Sud University (Paris Xi).
What are some of Bruno Besse's skills?
Bruno Besse has skills like
Cardiology,
Clinical Trials,
Medical Affairs,
Medicine,
Leadership,
Pharmaceutical Industry,
Clinical Development,
and
Clinical Research.
Who are Bruno Besse's colleagues?
Bruno Besse's colleagues are
Dalila Nafi,
Benoit Gueugnon,
Jean Pierre Riffaud,
Marie Noëlle Ly,
Jean Philippe Milon,
Lionel Segard,
and
Mariette Codou.
Who are Bruno Besse's peers at other companies?
Bruno Besse's peers at other companies are
Ahluwalia Hardeep,
Alka Chaubey,
Priya Sundaram,
Srinivasan Chakkarapani,
Ojuolape Kuti,
Richard Philipson,
and
Michael Lynch.